CANBEX THERAPEUTICS LIMITED - LONDON
Company Profile | Company Filings |
Overview
CANBEX THERAPEUTICS LIMITED is a Private Limited Company from LONDON ENGLAND and has the status: Active.
CANBEX THERAPEUTICS LIMITED was incorporated 20 years ago on 15/03/2004 and has the registered number: 05073720. The accounts status is MICRO ENTITY and accounts are next due on 30/04/2024.
CANBEX THERAPEUTICS LIMITED was incorporated 20 years ago on 15/03/2004 and has the registered number: 05073720. The accounts status is MICRO ENTITY and accounts are next due on 30/04/2024.
CANBEX THERAPEUTICS LIMITED - LONDON
This company is listed in the following categories:
72190 - Other research and experimental development on natural sciences and engineering
72190 - Other research and experimental development on natural sciences and engineering
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 7 | 31/07/2022 | 30/04/2024 |
Registered Office
2 ROYAL COLLEGE STREET
LONDON
NW1 0NH
ENGLAND
This Company Originates in : United Kingdom
Previous trading names include:
AXIMYGEN LIMITED (until 30/06/2005)
AXIMYGEN LIMITED (until 30/06/2005)
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
15/03/2023 | 29/03/2024 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR JESSE SCHULMAN | Jan 1952 | American | Director | 2013-03-01 | CURRENT |
DAVID LAWRENCE SELWOOD | Dec 1956 | British | Director | 2005-11-22 UNTIL 2013-04-11 | RESIGNED |
MRS HILARY ROTHERA | British | Secretary | 2007-01-12 UNTIL 2014-03-16 | RESIGNED | |
HOWARD THOMAS | May 1945 | Nominee Secretary | 2004-03-15 UNTIL 2005-03-22 | RESIGNED | |
MR WILLIAM ANDREW JOSEPH TESTER | Jun 1962 | British | Nominee Director | 2004-03-15 UNTIL 2005-03-22 | RESIGNED |
PROFESSOR HUMPHREY PETER RANG | Jun 1936 | British | Director | 2006-07-25 UNTIL 2007-01-03 | RESIGNED |
DR ABIGAIL WATTS | Aug 1977 | British | Director | 2011-04-02 UNTIL 2014-03-27 | RESIGNED |
MR CENGIZ ALTAN TARHAN | Dec 1958 | British | Director | 2005-03-15 UNTIL 2005-11-22 | RESIGNED |
DEAN MARC SLAGEL | Mar 1970 | British | Director | 2005-11-22 UNTIL 2019-04-25 | RESIGNED |
PASLEY-TYLER & COMPANY LIMITED | Corporate Secretary | 2014-03-24 UNTIL 2017-01-01 | RESIGNED | ||
DR STEPHANE ROBERT GEORGE MERY | Apr 1965 | French | Director | 2005-11-22 UNTIL 2011-11-24 | RESIGNED |
DR KEITH ADRIAN POWELL | Jul 1949 | British | Director | 2012-02-01 UNTIL 2019-07-08 | RESIGNED |
MR ROBERT RUDOLF KARL | May 1967 | German | Director | 2019-07-16 UNTIL 2022-02-16 | RESIGNED |
DR LARS GREDSTED | Feb 1974 | Danish | Director | 2014-11-26 UNTIL 2015-01-07 | RESIGNED |
DR LARS GREDSTED | Feb 1974 | Danish | Director | 2015-10-20 UNTIL 2017-11-10 | RESIGNED |
MR ROEL BULTHUIS | Mar 1976 | Dutch | Director | 2015-03-30 UNTIL 2019-01-01 | RESIGNED |
DR ANDREW JOHN WOOD | Oct 1955 | British | Director | 2013-04-11 UNTIL 2018-06-30 | RESIGNED |
MARK JOHN FLEMMING | British | Secretary | 2005-03-22 UNTIL 2007-01-12 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Mr Jesse Schulman | 2019-11-28 | 1/1952 | London |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Rusbio Ventures Limited Partnership | 2019-07-16 - 2019-11-28 | Moscow |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
|
The Wellcome Trust Ltd | 2016-04-06 - 2019-07-16 | London |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Accounts Submission | 2024-04-26 | 31-07-2023 | £1,110 equity |
Micro-entity Accounts - CANBEX THERAPEUTICS LIMITED | 2023-04-28 | 31-07-2022 | £2,962 equity |
Accounts Submission | 2022-05-04 | 31-07-2021 | £16,407 equity |
Micro-entity Accounts - CANBEX THERAPEUTICS LIMITED | 2021-06-02 | 31-07-2020 | £35,957 equity |
CANBEX THERAPEUTICS LIMITED | 2020-03-31 | 31-07-2019 | £513,614 Cash £603,876 equity |